Thelansis

  Atrophic vaginitis is an inflammatory condition associated with vaginal atrophy caused by reduced estrogen levels, mainly occurring during menopause. Vaginal atrophy leads to thinning of the vaginal epithelium, decreased vaginal rugae and elasticity, and reduced vaginal secretions. It affects premenopausal women and up to 50% of postmenopausal women. The hypoestrogenic state responsible for atrophic vaginitis can result from natural menopause or be induced by medical interventions like surgery, radiation, chemotherapy, or certain medications such as Selective estrogen receptor modulators, Selective estrogen receptor degraders, and antigonadotropins. Lower estrogen levels cause alterations in the vaginal environment, disrupting the normal flora, leading to an overgrowth of skin and rectal pathogens due to decreased Lactobacillus spp. The diagnosis of atrophic vaginitis is typically based on the patient's history and specific physical examination findings. Symptoms include vagina...